Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.

 

 

2019

Evotec and GARDP announce new partnership to discover novel antibiotics
Nerina Coppini, 19 March 2019

Collaboration explores opportunities to set up antibiotic discovery and development platform and establish a joint pipeline of novel antibiotic assets Discovery efforts will focus on World Health Organisation (“WHO”) priority pathogens

Evotec and Galapagos enter into collaboration in the field of Fibrosis
Nerina Coppini, 7 February 2019

Collaboration comprises licence agreement for a programme developed by Evotec as well as its drug discovery capabilities Evotec receives undisclosed upfront payment, adn is eligible for potential milestones as well as royalty payments

Evotec receives milestone payment for start of Phase II clinical trial
Nerina Coppini, 24 January 2019

Evotec's partner, Second Genome, begins a Phase II Clinical trial for NASH with licensed molecule,

2018

Evotec and LEO Pharma form drug discovery alliance targeting dermatological conditions
Nerina Coppini, 4 December 2018

Identify new leads for innovative targets in the dermatology field The alliance will use Evotec's world leading drug discovery platform

Evotec and Immuneering to collaborate on Artificial Intelligence (“AI”) driven ligand identification for rare hereditary metabolic diseases
Nerina Coppini, 21 November 2018

Combination of cutting-edge IPSC and AI technologies creates opportunity to discover novel metabolic ligands to accelerate drug discovery in rare metabolic diseases

Ferring and Evotec form strategic research alliance in reproductive medicine and women’s health
Nerina Coppini, 17 October 2018

Ferring accesses Evotec's integrated small molecule discovery and development platform to progress new molecules from concept to potential drug candidates Evotec is eligible for undisclosed research funding and milestones 

Evotec and Celgene expand IPSC collaboration to include additional cell lines
Nerina Coppini, 11 October 2018

$ 6 M payment to access additional cell lines

Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidates
Nerina Coppini, 4 October 2018

The creation of LAB031 is designed to translate academic research into drug discovery candidates Evotec aims to generate multiple lead candidates for Sanofi over three years across multiple therapeutic categories

Evotec publishes DDup 7 – Kidney diseases 2.0
Nerina Coppini, 28 September 2018

In this 7th DDup issue, we delve into the unique new kidney platforms poised to change the trajectory of kidney disease research and therapeutics development. Evotec has embarked on a novel collaboration model with Kidney Research UK, University of Bristol, University of Cambridge, University of Nottingham and the Mario Negri Institute in...

Evotec and Almirall enter into research collaboration in the field of dermatological diseases
Nerina Coppini, 17 September 2018

Collaboration is focused on first-in-class therapies to treat dermatological diseases Collaboration leverages a novel approach to disrupt cell signalling, validated by EVT Innovate

 

 

Contact us

Evotec

Business Development

T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308